| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA762757 | B | In vitro activity for the anti-oxytocic activity with out Mg2+. | 5 | single protein format | Scientific Literature | |||
| 2. | ALA882485 | B | In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+. | 6 | single protein format | Scientific Literature | |||
| 3. | ALA775215 | F | Antivasopressor activity in vivo in phenoxybenzamine pre-treated rats. | Rattus norvegicus | 22 | organism-based format | Scientific Literature | ||
| 4. | ALA773693 | F | In vivo activity for the anti-oxytocic activity. | Rattus norvegicus | 5 | organism-based format | Scientific Literature | ||
| 5. | ALA781668 | F | In vivo inhibition of estrogen induced changes in interuterine pressure in rats. | Rattus norvegicus | 22 | organism-based format | Scientific Literature | ||
| 6. | ALA781672 | F | Antidiuretic activity in rats as intravenous dose required for reduction of 2x agonist response to equal 1x effect in estrogen pretreated rats; Agonist | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA784738 | F | Dose that reduces blood pressure response in rats | 16 | tissue-based format | Scientific Literature | |||
| 8. | ALA784739 | F | Dose that reduces urine flow in water-loaded rats | 16 | tissue-based format | Scientific Literature | |||
| 9. | ALA799909 | F | Antioxytocic potencies (change in interuterine pressure) in vivo in estrogen pre-treated rats. | Rattus norvegicus | 22 | organism-based format | Scientific Literature | ||
| 10. | ALA878018 | F | Antioxytoxic activity in vitro in isolated uteri from estrogen pretreated rats suspended in Mg supplemented Dyke-Hastings solution. | Rattus norvegicus | 22 | organism-based format | Scientific Literature | ||
| 11. | ALA798117 | F | Antioxytoxic activity in vitro in isolated uteri from estrogen pretreated rats suspended in Mg supplemented Dyke-Hastings solution. | Rattus norvegicus | 22 | organism-based format | Scientific Literature | ||
| 12. | ALA799760 | F | Antivasopressor activity in vivo in phenoxybenzamine pre-treated rats. | Rattus norvegicus | 22 | organism-based format | Scientific Literature | ||
| 13. | ALA795983 | F | In vivo activity for the anti-oxytocic activity. | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA819384 | B | Anti-vasopressor activity at V1a receptor | Rattus norvegicus | 8 | single protein format | Scientific Literature | ||
| 15. | ALA818694 | B | Anti-vasopressor activity at V1a receptor | Rattus norvegicus | 7 | single protein format | Scientific Literature | ||
| 16. | ALA820239 | B | Antidiuretic activity at V2 receptor | Rattus norvegicus | 11 | tissue-based format | Scientific Literature | ||
| 17. | ALA820875 | B | Antidiuretic activity at V2 receptor | Rattus norvegicus | 2 | tissue-based format | Scientific Literature | ||
| 18. | ALA821339 | F | In vivo vasopressin V1-antagonistic activity was determined by measuring the blood pressure response in rats. | 16 | organism-based format | Scientific Literature | |||
| 19. | ALA821350 | F | In vivo antidiuretic V2-antagonistic activity was measured as changes in urine flow in water-loaded rats and is expressed as the negative logarithm of the ''effective dose divided by the estimated volume of distribution (67 mL/kg); ND denotes no d | 2 | organism-based format | Scientific Literature | |||
| 20. | ALA845125 | F | Ratio of antidiuretic V2 effective dose to that of vasopressin V1 effective dose; ND denotes no data | 2 | tissue-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!